News & Updates

Show Multimedia Only

BRAF, MEK Inhibitors linked to ocular adverse effects

07 Dec 2021

Treatment with BRAF and MEK inhibitors for metastatic melanoma is associated with several ocular adverse effects (OAE), a study has shown.

BRAF, MEK Inhibitors linked to ocular adverse effects

07 Dec 2021

Preoperative RT at a nonsarcoma centre may increase wound complications after resection

07 Dec 2021

In patients with soft tissue sarcoma (STS), preoperative radiation therapy (RT) performed at an academic cancer centre, as opposed to those done at a community centre, results in fewer wound complications following resection, according to a study.

Preoperative RT at a nonsarcoma centre may increase wound complications after resection

07 Dec 2021

Older women with cervical cancer face bleak outcomes

07 Dec 2021

Cervical cancer stands out as a major concern for older women who are frequently undertreated and are at higher risk of death, a study reports.

Older women with cervical cancer face bleak outcomes

07 Dec 2021

Levetiracetam associated with longer OS in IDH wild-type glioblastoma

07 Dec 2021 by

An observational single-institution cohort study provides evidence that levetiracetam use throughout the duration of standard chemotherapy is associated with longer median overall survival (OS) in patients with isocitrate dehydrogenase (IDH) wild-type glioblastoma.

Levetiracetam associated with longer OS in IDH wild-type glioblastoma

07 Dec 2021

Environmental ills linked to aggressive prostate cancer diagnosis

06 Dec 2021

Poor environmental quality is associated with greater odds of an advanced stage prostate cancer at diagnosis, with a study finding the strongest associations for lower water, land, sociodemographic quality.

Environmental ills linked to aggressive prostate cancer diagnosis

06 Dec 2021

Does enrolment in clinical trials improve survival in patients with multiple myeloma?

06 Dec 2021

Enrolment in clinical trials does not seem to increase survival among patients with multiple myeloma, a recent study has found.

Does enrolment in clinical trials improve survival in patients with multiple myeloma?

06 Dec 2021

PD-1 inhibitors outperform chemo in second-line treatment of advanced oesophageal cancer

06 Dec 2021

In the second-line treatment of patients advanced oesophageal cancer, the use of programmed cell death 1 (PD-1) inhibitors yields more favourable outcomes than chemotherapy across multiple patient subgroups, according to the results of a meta-analysis.

PD-1 inhibitors outperform chemo in second-line treatment of advanced oesophageal cancer

06 Dec 2021

Cisplatin-based chemotherapy boosts survival in muscle-invasive bladder cancer

05 Dec 2021

Cisplatin-based adjuvant chemotherapy confers substantial survival benefit in patients with muscle-invasive bladder cancer, reports a recent meta-analysis of randomized controlled trials (RCT).

Cisplatin-based chemotherapy boosts survival in muscle-invasive bladder cancer

05 Dec 2021

Long-term renal function decline common following radical cystectomy for bladder cancer

05 Dec 2021

Renal function considerably decreases over the long term for most bladder cancer patients who underwent radical cystectomy, a study has found.

Long-term renal function decline common following radical cystectomy for bladder cancer

05 Dec 2021

Actual body weight dosing of temozolomide offers survival benefits in glioblastoma

03 Dec 2021

Temozolomide administered to patients with glioblastoma at full actual body weight dosing during the concurrent phase is necessary to achieve a median overall survival (OS) that is similar to that seen in a previous trial, according to a recent study.

Actual body weight dosing of temozolomide offers survival benefits in glioblastoma

03 Dec 2021

News & Updates

Showing Oncology articles

Showing

Specialty:

BRAF, MEK Inhibitors linked to ocular adverse effects

BRAF, MEK Inhibitors linked to ocular adverse effects

Preoperative RT at a nonsarcoma centre may increase wound complications after resection

Preoperative RT at a nonsarcoma centre may increase wound complications after resection

Older women with cervical cancer face bleak outcomes

Older women with cervical cancer face bleak outcomes

Levetiracetam associated with longer OS in IDH wild-type glioblastoma

Levetiracetam associated with longer OS in IDH wild-type glioblastoma

Environmental ills linked to aggressive prostate cancer diagnosis

Environmental ills linked to aggressive prostate cancer diagnosis

Does enrolment in clinical trials improve survival in patients with multiple myeloma?

Does enrolment in clinical trials improve survival in patients with multiple myeloma?

PD-1 inhibitors outperform chemo in second-line treatment of advanced oesophageal cancer

PD-1 inhibitors outperform chemo in second-line treatment of advanced oesophageal cancer

Cisplatin-based chemotherapy boosts survival in muscle-invasive bladder cancer

Cisplatin-based chemotherapy boosts survival in muscle-invasive bladder cancer

Long-term renal function decline common following radical cystectomy for bladder cancer

Long-term renal function decline common following radical cystectomy for bladder cancer

Actual body weight dosing of temozolomide offers survival benefits in glioblastoma

Actual body weight dosing of temozolomide offers survival benefits in glioblastoma